EFMC Young Scientists Network
@youngscinet.bsky.social
Pinned
🧡 We've officially moved to Bluesky! 🧡
While we’ve loved connecting with you on X/Twitter, it's time for a fresh start in a platform that aligns with our values & vision.
Join the conversation & stay updated with all things EFMC-YSN. Let’s build an inclusive and sustainable community together.
While we’ve loved connecting with you on X/Twitter, it's time for a fresh start in a platform that aligns with our values & vision.
Join the conversation & stay updated with all things EFMC-YSN. Let’s build an inclusive and sustainable community together.
Join Wiktor Szymanski, Nadja A. Simeth-Crespi, Johannes Broichhagen, and Jana Volaric for MedChemBioOnline on Photopharmacology.
Discover innovative light-responsive compounds used in modulating biological functions.
📅 Nov. 25
🔗 buff.ly/umzJAAr
Discover innovative light-responsive compounds used in modulating biological functions.
📅 Nov. 25
🔗 buff.ly/umzJAAr
November 12, 2025 at 4:07 PM
Join Wiktor Szymanski, Nadja A. Simeth-Crespi, Johannes Broichhagen, and Jana Volaric for MedChemBioOnline on Photopharmacology.
Discover innovative light-responsive compounds used in modulating biological functions.
📅 Nov. 25
🔗 buff.ly/umzJAAr
Discover innovative light-responsive compounds used in modulating biological functions.
📅 Nov. 25
🔗 buff.ly/umzJAAr
📃 EFMC Literature Spotlight 📃
This edition’s contribution will focus on the recently published article “Novel Pyrazolo [1,5-a]−1,3,5-Triazine Derivatives as CDK7 Inhibitors: Synthesis and Biological Insights in Pancreatic Ductal Adenocarcinoma Models” by D. Carbone et al.
🔗 buff.ly/Glod3p1
This edition’s contribution will focus on the recently published article “Novel Pyrazolo [1,5-a]−1,3,5-Triazine Derivatives as CDK7 Inhibitors: Synthesis and Biological Insights in Pancreatic Ductal Adenocarcinoma Models” by D. Carbone et al.
🔗 buff.ly/Glod3p1
chemistry-europe.onlinelibrary.wiley.com
November 11, 2025 at 4:02 PM
📃 EFMC Literature Spotlight 📃
This edition’s contribution will focus on the recently published article “Novel Pyrazolo [1,5-a]−1,3,5-Triazine Derivatives as CDK7 Inhibitors: Synthesis and Biological Insights in Pancreatic Ductal Adenocarcinoma Models” by D. Carbone et al.
🔗 buff.ly/Glod3p1
This edition’s contribution will focus on the recently published article “Novel Pyrazolo [1,5-a]−1,3,5-Triazine Derivatives as CDK7 Inhibitors: Synthesis and Biological Insights in Pancreatic Ductal Adenocarcinoma Models” by D. Carbone et al.
🔗 buff.ly/Glod3p1
👨🔬 Have you read our latest hashtag#MedChemBioConversation ?
Get to know Samuele Cazzamalli from Philochem AG, Switzerland!🧪
Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice.
🔗 buff.ly/70Fu4wv
Get to know Samuele Cazzamalli from Philochem AG, Switzerland!🧪
Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice.
🔗 buff.ly/70Fu4wv
November 10, 2025 at 5:01 PM
👨🔬 Have you read our latest hashtag#MedChemBioConversation ?
Get to know Samuele Cazzamalli from Philochem AG, Switzerland!🧪
Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice.
🔗 buff.ly/70Fu4wv
Get to know Samuele Cazzamalli from Philochem AG, Switzerland!🧪
Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice.
🔗 buff.ly/70Fu4wv
📰 The November issue of MedChemBioWatch has arrived! 📰
Dive into our newest newsletter edition, explore our latest updates, and ensure you stay informed about our upcoming events.
🔗 buff.ly/xazhYlo
Dive into our newest newsletter edition, explore our latest updates, and ensure you stay informed about our upcoming events.
🔗 buff.ly/xazhYlo
November 6, 2025 at 4:02 PM
📰 The November issue of MedChemBioWatch has arrived! 📰
Dive into our newest newsletter edition, explore our latest updates, and ensure you stay informed about our upcoming events.
🔗 buff.ly/xazhYlo
Dive into our newest newsletter edition, explore our latest updates, and ensure you stay informed about our upcoming events.
🔗 buff.ly/xazhYlo
📢 The next Publishing Academy edition is approaching!
Join professional editors from Chemistry Europe / Wiley-VCH for a one-day course on writing, publishing, and communication, ideal for early-career researchers.
📅 November 13
⏰ Register by November 10
🔗 buff.ly/Wt7jvqE
Join professional editors from Chemistry Europe / Wiley-VCH for a one-day course on writing, publishing, and communication, ideal for early-career researchers.
📅 November 13
⏰ Register by November 10
🔗 buff.ly/Wt7jvqE
November 6, 2025 at 12:01 PM
📢 The next Publishing Academy edition is approaching!
Join professional editors from Chemistry Europe / Wiley-VCH for a one-day course on writing, publishing, and communication, ideal for early-career researchers.
📅 November 13
⏰ Register by November 10
🔗 buff.ly/Wt7jvqE
Join professional editors from Chemistry Europe / Wiley-VCH for a one-day course on writing, publishing, and communication, ideal for early-career researchers.
📅 November 13
⏰ Register by November 10
🔗 buff.ly/Wt7jvqE
⚠️ Less than 10 days to register ! ⚠️
On November 20th, MedChemBioPoster Online (#MCBPoster25) is back!
🏆 Prizes up to 150 euros
⏳ Deadline: November 13th
🔗 www.efmc.info/web/medchemb...
On November 20th, MedChemBioPoster Online (#MCBPoster25) is back!
🏆 Prizes up to 150 euros
⏳ Deadline: November 13th
🔗 www.efmc.info/web/medchemb...
November 5, 2025 at 4:45 PM
⚠️ Less than 10 days to register ! ⚠️
On November 20th, MedChemBioPoster Online (#MCBPoster25) is back!
🏆 Prizes up to 150 euros
⏳ Deadline: November 13th
🔗 www.efmc.info/web/medchemb...
On November 20th, MedChemBioPoster Online (#MCBPoster25) is back!
🏆 Prizes up to 150 euros
⏳ Deadline: November 13th
🔗 www.efmc.info/web/medchemb...
📃 EFMC Literature Spotlight 📃
This edition’s provided by Alex Hallatt (University of Dundee, UK) focuses on the article “Inhibition of the Clathrin Terminal Domain—Amphiphysin Protein–Protein Interaction. Probing the Pitstop 2 Aromatic Moiety” by K. Prichard, et al. (ChemMedChem 2025)
This edition’s provided by Alex Hallatt (University of Dundee, UK) focuses on the article “Inhibition of the Clathrin Terminal Domain—Amphiphysin Protein–Protein Interaction. Probing the Pitstop 2 Aromatic Moiety” by K. Prichard, et al. (ChemMedChem 2025)
chemistry-europe.onlinelibrary.wiley.com
October 31, 2025 at 12:02 PM
📃 EFMC Literature Spotlight 📃
This edition’s provided by Alex Hallatt (University of Dundee, UK) focuses on the article “Inhibition of the Clathrin Terminal Domain—Amphiphysin Protein–Protein Interaction. Probing the Pitstop 2 Aromatic Moiety” by K. Prichard, et al. (ChemMedChem 2025)
This edition’s provided by Alex Hallatt (University of Dundee, UK) focuses on the article “Inhibition of the Clathrin Terminal Domain—Amphiphysin Protein–Protein Interaction. Probing the Pitstop 2 Aromatic Moiety” by K. Prichard, et al. (ChemMedChem 2025)
Do not miss the 7th EFMC² Tandem Talks!
Join Timo Heinrich, Jakub Gunera and Jesko Fabian Kaiser (Merck, Germany) as they discuss "Investigation of P-site-binding TEAD Inhibitors: Structure-based Optimization and Mode of Action Elucidation".
📅 Dec 4 - 4pm CET
🔗 buff.ly/eQnLJIm
Join Timo Heinrich, Jakub Gunera and Jesko Fabian Kaiser (Merck, Germany) as they discuss "Investigation of P-site-binding TEAD Inhibitors: Structure-based Optimization and Mode of Action Elucidation".
📅 Dec 4 - 4pm CET
🔗 buff.ly/eQnLJIm
October 30, 2025 at 5:02 PM
Do not miss the 7th EFMC² Tandem Talks!
Join Timo Heinrich, Jakub Gunera and Jesko Fabian Kaiser (Merck, Germany) as they discuss "Investigation of P-site-binding TEAD Inhibitors: Structure-based Optimization and Mode of Action Elucidation".
📅 Dec 4 - 4pm CET
🔗 buff.ly/eQnLJIm
Join Timo Heinrich, Jakub Gunera and Jesko Fabian Kaiser (Merck, Germany) as they discuss "Investigation of P-site-binding TEAD Inhibitors: Structure-based Optimization and Mode of Action Elucidation".
📅 Dec 4 - 4pm CET
🔗 buff.ly/eQnLJIm
👩🔬 Have you read our latest #MedChemBioConversation ?
Get to know Paria Anastasiou from Max-Planck Institute, DE.🔍
Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice.
🔗https://buff.ly/qayWsyu
Get to know Paria Anastasiou from Max-Planck Institute, DE.🔍
Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice.
🔗https://buff.ly/qayWsyu
October 29, 2025 at 4:03 PM
👩🔬 Have you read our latest #MedChemBioConversation ?
Get to know Paria Anastasiou from Max-Planck Institute, DE.🔍
Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice.
🔗https://buff.ly/qayWsyu
Get to know Paria Anastasiou from Max-Planck Institute, DE.🔍
Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice.
🔗https://buff.ly/qayWsyu
Academia is tough — burnout, imposter syndrome, and the pressure to publish can be overwhelming. 💭
Join us on Oct 10, 1PM for Under Pressure, a free virtual workshop on mental health in academia.
🎙 Lashuel, Cahill & Ho
👉 Register: www.efmc.info/mental-healt...
Join us on Oct 10, 1PM for Under Pressure, a free virtual workshop on mental health in academia.
🎙 Lashuel, Cahill & Ho
👉 Register: www.efmc.info/mental-healt...
October 8, 2025 at 11:01 AM
Academia is tough — burnout, imposter syndrome, and the pressure to publish can be overwhelming. 💭
Join us on Oct 10, 1PM for Under Pressure, a free virtual workshop on mental health in academia.
🎙 Lashuel, Cahill & Ho
👉 Register: www.efmc.info/mental-healt...
Join us on Oct 10, 1PM for Under Pressure, a free virtual workshop on mental health in academia.
🎙 Lashuel, Cahill & Ho
👉 Register: www.efmc.info/mental-healt...
Don't miss out on the EFMC² Tandem Talks where Hans Matter and Maria Méndez Pérez (Sanofi) will discuss Modern Computational Design Meets Late-Stage Functionalization: A New Class of RIPK1 Inhibitor.
📅 October 9 - 4 PM
🔗 buff.ly/1jaKQAQ
📅 October 9 - 4 PM
🔗 buff.ly/1jaKQAQ
October 7, 2025 at 11:15 AM
Don't miss out on the EFMC² Tandem Talks where Hans Matter and Maria Méndez Pérez (Sanofi) will discuss Modern Computational Design Meets Late-Stage Functionalization: A New Class of RIPK1 Inhibitor.
📅 October 9 - 4 PM
🔗 buff.ly/1jaKQAQ
📅 October 9 - 4 PM
🔗 buff.ly/1jaKQAQ
Join us for "Under Pressure: A Mental Health Conversation for the Academic Community," a virtual workshop to build resilience, support, and a healthier future in academia.
📅 October 10 - 1PM
🔗 buff.ly/CiXa7F8
Complete our anonymous survey to shape the discussion.
📝 buff.ly/H2NmBru
📅 October 10 - 1PM
🔗 buff.ly/CiXa7F8
Complete our anonymous survey to shape the discussion.
📝 buff.ly/H2NmBru
September 29, 2025 at 3:04 PM
Join us for "Under Pressure: A Mental Health Conversation for the Academic Community," a virtual workshop to build resilience, support, and a healthier future in academia.
📅 October 10 - 1PM
🔗 buff.ly/CiXa7F8
Complete our anonymous survey to shape the discussion.
📝 buff.ly/H2NmBru
📅 October 10 - 1PM
🔗 buff.ly/CiXa7F8
Complete our anonymous survey to shape the discussion.
📝 buff.ly/H2NmBru
🖥️ MedChemBio Posters Online is coming back !
📆 The event will take place on LinkedIn on November 20, 2025, from 10 AM to 6 PM CET. It’s open to any young researchers worldwide, whether from academia or industry.
▶️ More info & Registration on: buff.ly/4j57fID
📆 The event will take place on LinkedIn on November 20, 2025, from 10 AM to 6 PM CET. It’s open to any young researchers worldwide, whether from academia or industry.
▶️ More info & Registration on: buff.ly/4j57fID
September 24, 2025 at 3:02 PM
🖥️ MedChemBio Posters Online is coming back !
📆 The event will take place on LinkedIn on November 20, 2025, from 10 AM to 6 PM CET. It’s open to any young researchers worldwide, whether from academia or industry.
▶️ More info & Registration on: buff.ly/4j57fID
📆 The event will take place on LinkedIn on November 20, 2025, from 10 AM to 6 PM CET. It’s open to any young researchers worldwide, whether from academia or industry.
▶️ More info & Registration on: buff.ly/4j57fID
📃 EFMC Literature Spotlight 📃
This edition’s contribution provided by Massimiliano Runfola (University of Oxford, United Kingdom)“Identification of a New Interesting BAG3 Modulator Able to Disrupt Cancer-Related Pathways” by Dafne Ruggiero et al. (ChemMedChem 2025)
This edition’s contribution provided by Massimiliano Runfola (University of Oxford, United Kingdom)“Identification of a New Interesting BAG3 Modulator Able to Disrupt Cancer-Related Pathways” by Dafne Ruggiero et al. (ChemMedChem 2025)
Identification of a New Interesting BAG3 Modulator Able to Disrupt Cancer‐Related Pathways
Compound 2, identified through in-house screening and derived from SP18, exhibits high affinity for BAG3, as demonstrated by Surface Plasmon Resonance and docking studies. It induces a…
buff.ly
September 22, 2025 at 2:30 PM
📃 EFMC Literature Spotlight 📃
This edition’s contribution provided by Massimiliano Runfola (University of Oxford, United Kingdom)“Identification of a New Interesting BAG3 Modulator Able to Disrupt Cancer-Related Pathways” by Dafne Ruggiero et al. (ChemMedChem 2025)
This edition’s contribution provided by Massimiliano Runfola (University of Oxford, United Kingdom)“Identification of a New Interesting BAG3 Modulator Able to Disrupt Cancer-Related Pathways” by Dafne Ruggiero et al. (ChemMedChem 2025)
👩🔬 Have you read our latest #MedChemBioConversation ?
Get to know Gavriil Efthymios from Imperial College London, UK.🔍
Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice.
🔗https://buff.ly/JgcwZqf
Get to know Gavriil Efthymios from Imperial College London, UK.🔍
Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice.
🔗https://buff.ly/JgcwZqf
September 22, 2025 at 9:00 AM
👩🔬 Have you read our latest #MedChemBioConversation ?
Get to know Gavriil Efthymios from Imperial College London, UK.🔍
Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice.
🔗https://buff.ly/JgcwZqf
Get to know Gavriil Efthymios from Imperial College London, UK.🔍
Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice.
🔗https://buff.ly/JgcwZqf
📢 The 3rdnd Lunch & Learn session is coming!
Join us to explore "Direct-to-Biology Platforms to Accelerate Drug Discovery" with Dr Rebecca Stevens, Andreas Holmqvist and Dr Cassie Pratley.
📅 Oct 14, 13:00 CET.
🔗https://buff.ly/xpMDjcN
#DrugDiscovery
Join us to explore "Direct-to-Biology Platforms to Accelerate Drug Discovery" with Dr Rebecca Stevens, Andreas Holmqvist and Dr Cassie Pratley.
📅 Oct 14, 13:00 CET.
🔗https://buff.ly/xpMDjcN
#DrugDiscovery
September 19, 2025 at 10:30 AM
📢 The 3rdnd Lunch & Learn session is coming!
Join us to explore "Direct-to-Biology Platforms to Accelerate Drug Discovery" with Dr Rebecca Stevens, Andreas Holmqvist and Dr Cassie Pratley.
📅 Oct 14, 13:00 CET.
🔗https://buff.ly/xpMDjcN
#DrugDiscovery
Join us to explore "Direct-to-Biology Platforms to Accelerate Drug Discovery" with Dr Rebecca Stevens, Andreas Holmqvist and Dr Cassie Pratley.
📅 Oct 14, 13:00 CET.
🔗https://buff.ly/xpMDjcN
#DrugDiscovery
📰The September issue of MedChemBioWatch has arrived!📰
Check out our newest newsletter edition, uncover our latest updates, and ensure you're up-to-date with our forthcoming events.
Check out our newest newsletter edition, uncover our latest updates, and ensure you're up-to-date with our forthcoming events.
September 18, 2025 at 11:03 AM
📰The September issue of MedChemBioWatch has arrived!📰
Check out our newest newsletter edition, uncover our latest updates, and ensure you're up-to-date with our forthcoming events.
Check out our newest newsletter edition, uncover our latest updates, and ensure you're up-to-date with our forthcoming events.
The schedule is out!
Join Hans Matter and Maria Méndez Pérez from Sanofi to discuss "Modern Computational Design Meets Late-Stage Functionalization: A New Class of RIPK1 Inhibitors." Tim Knehans will showcase how Schrödinger aids life science innovation.
📅 October 9 - 4pm
🔗 buff.ly/KINI5tx
Join Hans Matter and Maria Méndez Pérez from Sanofi to discuss "Modern Computational Design Meets Late-Stage Functionalization: A New Class of RIPK1 Inhibitors." Tim Knehans will showcase how Schrödinger aids life science innovation.
📅 October 9 - 4pm
🔗 buff.ly/KINI5tx
September 11, 2025 at 3:02 PM
The schedule is out!
Join Hans Matter and Maria Méndez Pérez from Sanofi to discuss "Modern Computational Design Meets Late-Stage Functionalization: A New Class of RIPK1 Inhibitors." Tim Knehans will showcase how Schrödinger aids life science innovation.
📅 October 9 - 4pm
🔗 buff.ly/KINI5tx
Join Hans Matter and Maria Méndez Pérez from Sanofi to discuss "Modern Computational Design Meets Late-Stage Functionalization: A New Class of RIPK1 Inhibitors." Tim Knehans will showcase how Schrödinger aids life science innovation.
📅 October 9 - 4pm
🔗 buff.ly/KINI5tx
📢 Join the 6th EFMC² Tandem Talk!
Maria Méndez Pérez and Hans Matter from Sanofi will discuss Modern Computational Design Meets Late-Stage Functionalization: A New Class of RIPK1 Inhibitors.
Free and open to all, thanks to Schrödinger.
📆 October 9 | 16:00-17:00 CET
🔗 buff.ly/L3NXc0E
Maria Méndez Pérez and Hans Matter from Sanofi will discuss Modern Computational Design Meets Late-Stage Functionalization: A New Class of RIPK1 Inhibitors.
Free and open to all, thanks to Schrödinger.
📆 October 9 | 16:00-17:00 CET
🔗 buff.ly/L3NXc0E
August 28, 2025 at 1:02 PM
📢 Join the 6th EFMC² Tandem Talk!
Maria Méndez Pérez and Hans Matter from Sanofi will discuss Modern Computational Design Meets Late-Stage Functionalization: A New Class of RIPK1 Inhibitors.
Free and open to all, thanks to Schrödinger.
📆 October 9 | 16:00-17:00 CET
🔗 buff.ly/L3NXc0E
Maria Méndez Pérez and Hans Matter from Sanofi will discuss Modern Computational Design Meets Late-Stage Functionalization: A New Class of RIPK1 Inhibitors.
Free and open to all, thanks to Schrödinger.
📆 October 9 | 16:00-17:00 CET
🔗 buff.ly/L3NXc0E
📢 The 2nd Lunch & Learn session is coming!
Join us to explore "Protein Kinases as Drug Targets" with Dr. Ricardo Serafim, Ms. Elena Caballero Sánchez, and MSc. Marta Durán Martínez.
📅 Sep 11, 13:00 CET.
🔗https://buff.ly/wptBMwa
#DrugDiscovery #KinaseResearch
Join us to explore "Protein Kinases as Drug Targets" with Dr. Ricardo Serafim, Ms. Elena Caballero Sánchez, and MSc. Marta Durán Martínez.
📅 Sep 11, 13:00 CET.
🔗https://buff.ly/wptBMwa
#DrugDiscovery #KinaseResearch
August 14, 2025 at 11:00 AM
📢 The 2nd Lunch & Learn session is coming!
Join us to explore "Protein Kinases as Drug Targets" with Dr. Ricardo Serafim, Ms. Elena Caballero Sánchez, and MSc. Marta Durán Martínez.
📅 Sep 11, 13:00 CET.
🔗https://buff.ly/wptBMwa
#DrugDiscovery #KinaseResearch
Join us to explore "Protein Kinases as Drug Targets" with Dr. Ricardo Serafim, Ms. Elena Caballero Sánchez, and MSc. Marta Durán Martínez.
📅 Sep 11, 13:00 CET.
🔗https://buff.ly/wptBMwa
#DrugDiscovery #KinaseResearch
📃 EFMC Literature Spotlight 📃
This edition’s contribution provided by Dr Maria Korpidou focuses on the recently published article "Development of a Peptide Inhibitor Targeting the C-SH2 Domain of the SHP2 Phosphatase" by Azin Kiani et al., published in ChemBioChem
More at: doi.org/10.1002/cbic...
This edition’s contribution provided by Dr Maria Korpidou focuses on the recently published article "Development of a Peptide Inhibitor Targeting the C-SH2 Domain of the SHP2 Phosphatase" by Azin Kiani et al., published in ChemBioChem
More at: doi.org/10.1002/cbic...
August 7, 2025 at 4:20 PM
📃 EFMC Literature Spotlight 📃
This edition’s contribution provided by Dr Maria Korpidou focuses on the recently published article "Development of a Peptide Inhibitor Targeting the C-SH2 Domain of the SHP2 Phosphatase" by Azin Kiani et al., published in ChemBioChem
More at: doi.org/10.1002/cbic...
This edition’s contribution provided by Dr Maria Korpidou focuses on the recently published article "Development of a Peptide Inhibitor Targeting the C-SH2 Domain of the SHP2 Phosphatase" by Azin Kiani et al., published in ChemBioChem
More at: doi.org/10.1002/cbic...
📰The August issue of MedChemBioWatch has arrived!📰
Check out our newest newsletter edition, uncover our latest updates, and ensure you're up-to-date with our forthcoming events.
Check out our newest newsletter edition, uncover our latest updates, and ensure you're up-to-date with our forthcoming events.
August 5, 2025 at 4:04 PM
📰The August issue of MedChemBioWatch has arrived!📰
Check out our newest newsletter edition, uncover our latest updates, and ensure you're up-to-date with our forthcoming events.
Check out our newest newsletter edition, uncover our latest updates, and ensure you're up-to-date with our forthcoming events.
📖 EFMC Literature Spotlight
This edition’s contribution provided by Noemí Martínez Conde focuses on the recently published article “Advancing the Exploration of the Ubiquitin-like Protein FUBI with Synthetic Chemical Tools” by Francesca D’Amico, et al.
🔗Link: buff.ly/cjMWPGn
This edition’s contribution provided by Noemí Martínez Conde focuses on the recently published article “Advancing the Exploration of the Ubiquitin-like Protein FUBI with Synthetic Chemical Tools” by Francesca D’Amico, et al.
🔗Link: buff.ly/cjMWPGn
July 16, 2025 at 4:06 PM
📖 EFMC Literature Spotlight
This edition’s contribution provided by Noemí Martínez Conde focuses on the recently published article “Advancing the Exploration of the Ubiquitin-like Protein FUBI with Synthetic Chemical Tools” by Francesca D’Amico, et al.
🔗Link: buff.ly/cjMWPGn
This edition’s contribution provided by Noemí Martínez Conde focuses on the recently published article “Advancing the Exploration of the Ubiquitin-like Protein FUBI with Synthetic Chemical Tools” by Francesca D’Amico, et al.
🔗Link: buff.ly/cjMWPGn
⏰ ONLY ONE DAY TO GO!
Don't miss the 1st session of the YSN Lunch & Learn. Join Massimiliano Runfola, Amrita Date, and Josh Mealing-Stott as they delve into the use of Affinity-Based Proteome Profiling (ABPP) in chemical biology and drug discover.
📅 July 16 - 13:00 CET/12:00 UK
🔗 buff.ly/5uiuN7N
Don't miss the 1st session of the YSN Lunch & Learn. Join Massimiliano Runfola, Amrita Date, and Josh Mealing-Stott as they delve into the use of Affinity-Based Proteome Profiling (ABPP) in chemical biology and drug discover.
📅 July 16 - 13:00 CET/12:00 UK
🔗 buff.ly/5uiuN7N
July 15, 2025 at 10:00 AM
⏰ ONLY ONE DAY TO GO!
Don't miss the 1st session of the YSN Lunch & Learn. Join Massimiliano Runfola, Amrita Date, and Josh Mealing-Stott as they delve into the use of Affinity-Based Proteome Profiling (ABPP) in chemical biology and drug discover.
📅 July 16 - 13:00 CET/12:00 UK
🔗 buff.ly/5uiuN7N
Don't miss the 1st session of the YSN Lunch & Learn. Join Massimiliano Runfola, Amrita Date, and Josh Mealing-Stott as they delve into the use of Affinity-Based Proteome Profiling (ABPP) in chemical biology and drug discover.
📅 July 16 - 13:00 CET/12:00 UK
🔗 buff.ly/5uiuN7N
📰The July issue of MedChemBioWatch has arrived!📰
Check out our newest newsletter edition, uncover our latest updates, and ensure you're up-to-date with our forthcoming events.
🔗 www.efmc.info/medchemwatch...
Check out our newest newsletter edition, uncover our latest updates, and ensure you're up-to-date with our forthcoming events.
🔗 www.efmc.info/medchemwatch...
July 10, 2025 at 4:46 PM
📰The July issue of MedChemBioWatch has arrived!📰
Check out our newest newsletter edition, uncover our latest updates, and ensure you're up-to-date with our forthcoming events.
🔗 www.efmc.info/medchemwatch...
Check out our newest newsletter edition, uncover our latest updates, and ensure you're up-to-date with our forthcoming events.
🔗 www.efmc.info/medchemwatch...